iduneo builds the infrastructure that makes oncology trials in Europe faster, broader, and grounded in real clinical data — across networks, planning, execution, and evidence.
See what we doBeyond traditional recruitment or data: built for the speed, complexity, and stakes of modern oncology trials — and for the patients, clinicians, and sponsors who depend on them.
How your trial will actually run.
We model how a trial will progress before it starts — not a static feasibility snapshot.
For patients: a realistic sense of whether a trial near you will open and enroll.
For clinicians: sites chosen because they fit, not on guesswork.
For sponsors: commit with eyes open, not on assumptions.
Today's data. Today's patient.
In oncology, last year's data is already outdated. Treatments change, biomarker status shifts. iduneo works with current clinical documentation — so what you see is what's actually treatable now.
For patients: matched on your situation now, not a diagnosis from months ago.
For clinicians: built on your live documentation, not stale records.
For sponsors: see what's actually treatable now.
One site. Whole populations.
Through intelligent referral networks, a single clinical site reaches patient populations no individual hospital could.
For patients: access to trials your own hospital may not run.
For clinicians: stay in control of your patients while widening their options.
For sponsors: reach populations no single site could.
Not data points. People.
Why a treatment was switched. Why a patient declined. Why an outcome looked the way it did. iduneo captures the reasons and situations that structured data leaves out — the "why" behind every "what".
For patients: understood as a person, not a row of codes.
For clinicians: less manual documentation, structured capture.
For sponsors: the reasons behind switches, declines, and outcomes.
Predictive feasibility, site identification, and patient recruitment for oncology trials — Phase I through Phase III. Partner institutions identify eligible patients and refer them to your site, so a single center reaches populations far beyond its own catchment — no new sites, no added infrastructure. Live in DACH, with pilots in Spain, Italy, the UK, and France.
Real-world treatment patterns and disease burden in European oncology populations — extracted from the extended medical documentation that reflects actual care.
Direct relationships with pharmaceutical sponsors, from project-based studies to multi-year research collaborations.
Cross-institutional referral and data handling are built on European research and data protection law — structural, not bolted on.
"We need to look beyond traditional site-only recruitment. iduneo reaches new populations now and allows us to scale European-wide.
Pharmaceutical Partner · Clinical Operations
Clinical trials can give access to new therapies — often earlier than standard care. Many people don't know which trials might suit them, or how to take the first step.
Our patient service helps you understand whether a trial might be right for you, step by step, with personal support. Free, confidential, and active across Europe.
"Within 48 hours I had three concrete trial options.
Three weeks later, I was in study treatment.Patient · OnkoPlus DACH
iduneo gives your clinic access to oncology trials that match your actual patient population — and handles the work that normally stands between a clinic and a running trial.
iduneo gives your clinic access to oncology trials that match your actual patient population — not whatever happens to be available. We bring you top international research that might otherwise stay out of reach.
We help acquire suitable trials, support contracting and site activation, and prepare source data. The operational work that normally stands between your clinic and a running trial, taken off your plate before recruitment even starts.
Once a trial is running, iduneo handles pre-qualification, referral logistics, and coordination — so you see more patients within research protocols with less administrative load per enrolled patient.
Your time stays where it matters: with patients and clinical decisions.
"Super, super, super. This saves me so much time.
Oncologist · DACH Network
iduneo was founded in 2024 by a team combining oncology clinical expertise, AI & Digital engineering, and European pharmaceutical market knowledge. We are headquartered in Hamburg and active across DACH, with pilots in Italy, Spain, the UK, and France.
Our focus is narrow by design: clinical phase infrastructure for oncology, in Europe. We believe progress in trial efficiency comes not from more technology for its own sake — but from better use of the data and networks that already exist in clinical practice.
Whether you represent a pharmaceutical company, a treatment center, or a research institution — we would like to hear from you.